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Type 2 granular corneal dystrophy (GCD2) is
caused by point mutation R124H in the transform-
ing growth factor-–induced gene (TGFBI) and is
characterized by age-dependent progression of cor-
neal deposits. Mitochondrial features in heterozy-
gous GCD2 and normal corneal tissues was evalu-
ated using electron microscopy. Primary corneal
fibroblasts of homozygous and normal corneas
were cultured to passage 4 or 8. Keratocytes of nor-
mal corneal tissue are narrow, and details of their
intracellular organelles are difficult to distinguish.
Keratocytes of heterozygous GCD2 tissues exhibited
many degenerative mitochondria. MitoTracker and
cytochrome c staining demonstrated increased mi-
tochondrial activity in mutated cells at early pas-
sages. Decreases in depolarized mitochondria, cel-
lular proliferation, and expression of complexes I
to V and increases in apoptotic change were ob-
served in late-passage mutant fibroblasts. PGC-1,
ANT-1, p-Akt, and p-mTOR but not NF-B expression
demonstrated a passage-dependent decrease in all
cells. Increased passage- or mutation-related intra-
cellular reactive oxygen species and delayed prolif-
eration of methanethiosulfonate (MTS) were recov-
ered using application of antioxidant butylated
hydroxyanisole. Mitochondrial features and func-
tion were altered in mutated GCD2 keratocytes, in
particular in older cells. Alteration of mitochon-
drial function is critical for understanding the
pathogenesis of GCD2. (Am J Pathol 2011, 179:684–692;
DOI: 10.1016/j.ajpath.2011.04.005)
684The corneal manifestation of type 2 granular corneal dys-
trophy (GCD2) involves age-dependent progression of
opacity, with clinically severe vision impairment.1–3 The
size and number of deposits change slowly but worsen
progressively. A mutation of codon 124 that changes argi-
nine to histidine in the transforming growth factor -induced
gene (TGFBI, formerly known as BIGH3) on human chromo-
some 5 (5q31) causes the condition.4,5 This mutation is also
responsible for abnormal protein deposits in the corneal
stroma of GCD2. The major component of these deposits is
TGFBI protein (TGFBIp, also known as BIGH3).6,7 TGFBIp
contains an N-terminal signal peptide that targets the pro-
tein to the lumen of the endoplasmic reticulum and the
trans-Golgi network for eventual secretion.8–10 The corneal
dystrophy–associated R124H mutation causes aberrant re-
distribution of the mutant TGFBI into lysosomes.8 Excessive
accumulation of mutated protein are observed in the cyto-
plasm, and this abnormal distribution may influence cellular
metabolism.
Mitochondria are essential to cellular metabolism and
cell survival, and any deviation from their normal opera-
tion is certainly fatal. Aging is frequently characterized by
accumulation of altered proteins and dysfunctional mito-
chondria. The effect of energy metabolism on proteosta-
sis, in particular the formation and elimination of altered
proteins, is also vital to cell survival and degeneration.11
In other diseases associated with abnormal protein ac-
cumulation such as Alzheimer disease, increasing oxida-
tive stress and altered mitochondrial dynamics contribute
to the course of the disease and functional decline.12 The
accumulation of mutated protein in GCD2, which be-
comes diverted from the ordinary protein secretion path-
way, may induce intracellular damage and an altered
intracellular metabolic state by affecting mitochondrial
function. Moreover, extracellular deposits of mutated pro-
tein could lead to cellular toxicity.
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AJP August 2011, Vol. 179, No. 2In the present study, we compared the structure and
function of mitochondria in wild-type and GCD2 mutated
corneal tissues and fibroblasts, and observed that the
GCD2 mutation alters mitochondrial function, potentially ex-
plaining the age-dependent progression of the disease.
Materials and Methods
Corneal Tissues
Corneal tissues were obtained during keratoplasty from
patients with GCD2, in whom DNA analysis confirmed
heterozygosity for the R124H TGFBI gene mutation.
Healthy corneal tissues were supplied by the Yonsei Uni-
versity Eye Bank. The study was performed in accor-
dance with the Helsinki agreement, and informed con-
sent was obtained from all patients. Corneas were stored
in 2.5% glutaraldehyde in PBS solution overnight at 4°C.
Primary Culture of Homozygote and Wild-Type
Corneal Fibroblasts
Primary corneal fibroblast cultures were prepared from
healthy corneas from 20-year-old donors obtained from the
eye bank or from mutant corneal fibroblasts from 8-year-
old patients homozygous for GCD2 after penetrating ker-
atoplasty (cornea tissue study approved by Severance
Hospital Institutional Review Board, IRB-2006-0139). Ho-
mozygous GCD2 diagnoses were based on the results of
DNA analysis for the R124H TGFBIp gene mutation using
peripheral blood samples. Stromal explants were pre-
pared by removing the epithelium and endothelium and
culturing in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum at
37°C in 5% CO2 in six-well tissue culture plates. Corneal
fibroblasts migrated from the explants along the bottom
of the plates. Cells were confluent within 15 to 21 days,
after which they were enzymatically detached using
0.05% trypsin at 37°C for 3 minutes and centrifuged at
1400 rpm for 5 minutes, and the supernatant was re-
moved. The cell pellet was resuspended in 20 mL me-
dium and cultured in 75-mL flasks at 37°C in 5% CO2 until
confluent. Cells were then serially trypsinized and pas-
saged three or seven times before use in experiments. In
preparation for experiments, cells were plated at concen-
trations of 3 to 5  103 per well in 96-well tissue culture
plates and incubated in 1 mL 10% FBS in DMEM at 37°C
in 5% CO2 for 24 to 48 hours.
Transmission Electron Microscopic Examination
of Wild-Type and Mutant Corneal Tissue and
Fibroblasts
Corneal tissue or cultured cells were fixed in 1% OsO4 in
phosphate buffer for approximately 90 minutes at room
temperature, washed twice in phosphate-buffered fixa-
tive vehicle, and dehydrated in a graded ethanol series.
The transition from 100% ethanol to epoxy was mediated
by two changes of propylene oxide, and a pure epoxy
medium was used for infiltration and embedding. Thefragments were mounted in flat molds and hardened at
80°C overnight before sectioning. Both 600- to 1000-nm
sections and 60- to 80-nm sections for transmission elec-
tron microscopy were cut onto polyvinyl butyral–coated
grids (Pioloform; Sigma-Aldrich Corp., St. Louis, MO).
One-micrometer to 2-m sections were stained using
alkaline toluidine blue and previewed using light micros-
copy to select areas for electron microscopic analysis.
Selected sections were stained using saturated aqueous
uranyl acetate and lead citrate. Evaluation was per-
formed using a transmission electron microscope
(JEM1200 EX2; JEOL Ltd., Tokyo, Japan).
MitoTracker and Cytochrome c Staining
Mitochondria were detected using MitoTracker stock so-
lution (Invitrogen Corp., Carlsbad, CA). Cells were plated
in two-well chambers, 1  104 cells per well. After 24
hours, cells were incubated with 10% fetal bovine serum
in DMEM, washed with fresh prewarmed serum-free
DMEM, and fixed in DMEM containing 4% formaldehyde
for 1 hour. After incubating with PBS containing 0.2%
Triton X-100 for 10 minutes, the cells were washed with
PBS containing 0.02% Tween-20 and treated with 1%
bovine serum albumin for 5 minutes. Then the cells were
stained with 1 mmol/L MitoTracker Red 580 (Molecular
Probes, Inc., Eugene, OR) for 30 minutes. After staining,
cells were washed three times with serum-free DMEM.
For cytochrome c staining, cells were incubated with goat
anti–cytochrome c antibody (Abcam, Inc., Cambridge, MA)
to a final working concentration of 1:650 in PBS containing
3% bovine serum albumin. After several washes in buffer,
fluorescein isothiocyanate (green)–labeled anti-mouse IgG
(1:200 dilution; Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA) was applied as a secondary anti-
body. Images of stained cells were acquired using a con-
focal microscope (TCS-SP5; Leica Microsystems Inc., Ban-
nockburn, IL), and were analyzed using Scion Image
software (Scion Corp., Frederick, MD).
Annexin V Staining
Cells were stained with annexin V (BioVision, Inc., Moun-
tain View, CA) and incubated with avidin–horseradish
peroxidase complex (1:300), and binding was visualized
using 0.05% diaminobenzidine or 0.01% H2O2 solution.
Cells were photographed using a fluorescence micro-
scope equipped with an annexin V filter.
JC-1 Assay for Mitochondrial Membrane
Potential
The mitochondrial membrane potential was assayed us-
ing the MitoProbe JC-1 Assay Kit for Flow Cytometry
(Molecular Probes, Inc.) according to the manufacturer’s
directions. In brief, cells were washed and then incu-
bated with 2 mol/L JC-1 at 37°C in 5% CO2 for 30
minutes. Cells were washed with 2 mL PBS and pelleted
using centrifugation, then resuspended in 500 L PBS.
Cells were analyzed using a flow cytometer with 488-nm
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488 dye (Molecular Probes, Inc.) and R-phycoerythrin. The
dye, which exists as a green fluorescent monomer (excita-
tion, 485 nm; emission, 535 nm) in the cytosol, is absorbed
by healthy mitochondria and forms a red fluorescent aggre-
gate (excitation, 550 nm; emission, 600 nm).
MTS and CCK-8 Assay
Cell proliferation was measured using the methanethio-
sulfonate [MTS; 3-(4,5-dimethylthiazol-2-yl)5-(3-carboxy-
methoxyphenyl)2-(4-sulfophenyl)-2H-tetrazolium] mix–
based cell titer assay and Cell Counting Kit-8 (CCK-8)
assay after 6, 24, and 48 hours of culture. Cells were
plated in 96-well plates at 1  104 cells per well over-
night. Cell proliferation was determined using the Cell
Figure 1. Electron microscopic images of wild-type and mutant corneal
tissue and fibroblasts. A: Keratocytes of healthy cornea demonstrate the
characteristic narrow spindle shape. B: Cytoplasm of the cell shows dense
color, and details of the intracellular organelles are barely discernible. C:
Enlarged keratocytes of heterozygous corneal tissue clearly demonstrate
intracellular organelles. Some keratocytes encircled the deposits and ex-
tended cellular processes that reach the abnormal deposits (black arrow).
D: Cells contained many dilated or degenerative mitochondria and vesicles
containing amorphous material (white arrow). Original magnification:
2000 (A); 10,000 (B–D).
Figure 2. Electron microscopic images of cultured corneal fibroblasts.
Wild-type cultured fibroblasts contain small round mitochondria and
other cellular components such as endoplasmic reticulum (black arrow)
in passage 4 (A) and Golgi complex (white arrow) in passage 8 (B). C:
Homozygote cultured fibroblasts demonstrate elongated and swollen mi-
tochondria with increasing numbers throughout the cytoplasm and lim-
ited numbers of other intracellular organelles. D: In late-passage homozy-
gous mutant corneal fibroblasts, disorganized and dilated mitochondria
with decreased numbers are observed.Titer 96 AQueous One Solution Reagent Cell Proliferation
Assay Kit with the tetrazolium compound (inner salt;
MTS. (Promega Corp., Madison, WI). In brief, the cul-
ture medium was removed, and 20 L MTS solution
was added to each well in 100 L culture medium. The
reaction was terminated by adding 10% SDS, and op-
tical density was measured using a plate reader with a
filter setting at 450 nm.
For the CCK-8 assay, 10 L CCK-8 solution (Dojindo
Laboratories, Kumamoto, Japan) was added to each well
in 100 L culture medium. The cultures were incubated at
37°C for 2 to 4 hours under 95% humidity and 5% CO2.
Optical density was measured using a plate reader with a
filter setting of 490 nm.
Western Blot Analysis
Cells were lysed by incubation in 50 mmol/L Tris HCl (pH
7.5), 120 mmol/L NaCl, 20 mmol/L NaF, 1 mmol/L EDTA,
5 mmol/L EGTA, 15 mmol/L sodium pyrophosphate, 30
mmol/L p-nitrophenyl phosphate, 1 mmol/L benzamidine,
0.1 mmol/L phenylmethylsulfonyl fluoride, and 1% Nonidet
P-40 for 20minutes at 4°C and centrifuged at 15,000 g for
15 minutes at 4°C. Cell lysates were boiled in Laemmli’s
sample buffer for 3 minutes, and 30 g protein was
subjected to SDS-PAGE. Proteins were then transferred
to polyvinylidene difluoride membranes. The membranes
were blocked for 30 minutes in Tris-buffered saline solu-
tion containing 0.1% Tween-20 and 5% (w/v) dry skim
milk powder, then incubated overnight with primary anti-
bodies [Total OXPHOS Complexes Detection Kit (1:
1000); Mitosciences Inc., Eugene, OR], PGC-1 (Novus
Biologicals, LLC, Littleton, CO), ANT-1 (Abcam Inc.),
VDAC (Cell Signaling Technology, Inc., Beverly, MA),
mTsR, p-mTor (Ser 2448, Ser2481) Akt, or p-Akt (Ser473,
Figure 3. MitoTracker and cytochrome c staining of wild-type and mutant
corneal fibroblasts from passages 4 and 8. Wild-type cells demonstrate similar
intensity of MitoTracker and cytochrome c staining in passages 4 and 8.
Mutant corneal fibroblasts exhibit strong intensity of MitoTracker and cyto-
chrome c staining in passage 4. However, in passage 8, the intensity of both
markers is decreased significantly. *P  0.05; Student’s t-test, passage 4
versus passage 8.Thr 308) (Cell Signaling Technology, Inc.). Nuclear ex-
Altered Mitochondrial Function in GCD2 687
AJP August 2011, Vol. 179, No. 2traction was performed using NE-PER Nuclear and Cyto-
plasmic Extraction Reagents (Thermo Fisher Scientific
Inc., Waltham, MA), and the membranes were incubated
with primary antibody of NF-B (1:1000) (Cell Signaling
Technology, Inc.) or PGC-1. The membranes were then
washed with Tris-buffered saline solution containing 0.1%
Tween-20, incubated for 1 hour with a secondary anti-
body, and visualized using an enhanced chemilumines-
cence detection kit (Amersham Life Science, Arlington
Heights, IL).
Measurement of Reactive Oxygen Species
Production
Intracellular reactive oxygen species (ROS) generation was
measured using CM-H2DCFDA (5,6-chloromethyl- 2=,7=-di-
chlorodihydrofluorescein diacetate) (Molecular Probes,
Inc.). Cells, 3  105, were plated on 35-mm dishes and
cultured for 24 hours. The cells were co-cultured with or
without 100 mol/L butylated hydroxyanisole (BHA) in phe-
nol red–free medium. After stimulation, the cells were rinsed
once with 2 mL Kreb’s-Ringer’s solution and incubated for 5
minutes with 5 mol/L CM-H2DCFDA. The plate was
mounted, and the dichlorofluorescein (DCF) fluorescence
Figure 4. JC-1 assay of wild-type and mutant corneal fibroblasts in passages
4 and 8. A: Dot plot demonstrates increasing numbers of dots in the lower
part in passage 8 mutant cells. B: Graph indicates the ratio of red to green
fluorescence, which is decreased in mutant corneal fibroblasts, especially in
passage 8. *P  0.05; Student’s t-test, passage 4 versus passage 8.images were immediately acquired using fluorescence mi-croscopy (Axiovert 200; Carl Zeiss MicroImaging, Inc.,
Thornwood, NY). Finally, the fluorescence intensities of 80
to 100 cells were measured and averaged using a Scion
imaging system.
Statistical Analysis
Analysis of variance was used to compare cell viability
detected in MTS and CCK-8 assays. The results for in-
tensity of staining, the ratio of red to green fluorescence,
expression of protein complexes, and expression of mi-
tochondria-related factors were analyzed using the Stu-
dent’s t-test. Statistical analysis was performed using
commercially available software (SigmaStat 3.5; Systat
Software, Inc., San Jose, CA).
Results
Altered Mitochondrial Number and Structure in
Mutant Corneal Tissue and Fibroblasts
The keratocytes of normal cornea have a characteristic
narrow spindle shape. The cytoplasm of the cells is densely
colored, and the intracellular organelles are barely discern-
ible. The keratocytes of heterozygous GCD2 corneal tissue,
in particular near the stromal deposits, were enlarged, and
the intracellular organelles were clearly visible. These cells
contained many dilated or degenerative mitochondria and
vesicles containing amorphous material. Some of the kerato-
Figure 5. MTS and CCK-8 assays of wild-type and mutant corneal fibroblasts
in passages 4 and 8. A: Wild-type corneal fibroblasts in passages 4 and 8 and
mutant cells in passage 4 demonstrate time-dependent proliferation in both
the MTS and CCK-8 assays. However, the column of mutant corneal fibro-
blasts in passage 8 after 48 hours is significantly smaller in both assays. *P 
0.05; analysis of variance, passage 4 versus passage 8. B: At annexin V
staining, cells undergoing apoptosis experienced cytoplasmic shrinkage and
perimembranous stippling. GCD2 homozygote cells demonstrate typical
characteristics of apoptosis in both passages, whereas such staining is less
apparent in both passages of wild-type cells.
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reached the abnormal deposits (Figure 1). Wild-type cul-
tured fibroblasts contained small round mitochondria and
other cellular components in passages 4 and 8, whereas
the homozygous mutant cells demonstrated elongated and
swollen mitochondria with increasing numbers throughout
the cytoplasm and limited numbers of other intracellular
organelles. In passage 8 cultures of corneal fibroblasts with
the homozygous genotype, fewer disorganized and dilated
mitochondria were observed (Figure 2).
Decreased Mitochondrial Activity in
Late-Passage Mutant Cells
Compared with wild-type corneal fibroblasts, passage 4
mutant corneal fibroblasts exhibited strongMitoTracker and
cytochrome c staining, which detect mitochondrial activity.
Wide enlarged cellular contours were also observed in the
mutant cells. In passage 8, MitoTracker and cytochrome c
staining intensity of mutant corneal fibroblasts decreased,
whereas staining in the wild-type corneal fibroblasts was
unchanged. The intensity of staining was analyzed, and in
both staining procedures, a statistically significant decrease
was observed in mutant cells in passage 8 compared with
mutant cells in passage 4 (Figure 3).
Decreased Mitochondrial Depolarization in
Late-Passage Mutant Corneal Fibroblasts
When the mitochondrial membrane potential (m) is
high, JC-1 accumulates in the mitochondrial matrix by
forming J-aggregates with red fluorescence. However,
Figure 6. Western blot analysis of complexes I to V of wild-type and mutan
statistically significantly reduced in late passages of mutant corneal fibroblas
of complexes I, II, IV, and V were unchanged in wild-type. The y axis of each gra
fibroblasts in passage 4 as 1.0.when the mitochondrial membrane potential is low, JC-1
is a monomer with green fluorescence. A dot plot of red
fluorescence versus green fluorescence differentiates
live cells with intact mitochondrial membrane potential
from apoptotic and dead cells with lost mitochondrial
membrane potential. The ratio of red to green fluores-
cence did not change in wild-type corneal fibroblasts;
however, it was decreased in mutant corneal fibroblasts,
in particular in passage 8 (Figure 4).
Decreased Viability of Mutant Corneal
Fibroblasts
Wild-type corneal fibroblasts in passages 4 and 8 and
mutant cells in passage 4 demonstrated time-depen-
dent increases in detection of MTS and CCK-8. How-
ever, the rate of increase in MTS and CCK-8 detection
was slowed in mutant corneal fibroblasts in passage 8
at 24 and 48 hours (Figure 5A). At annexin V staining,
cytoplasmic shrinkage and perimembranous stippling
were observed more frequently in the GCD2 homozy-
gote cells in both passages, whereas such staining
was less apparent in wild-type cells in both passages
(Figure 5B).
Expression of Mitochondrial Enzymes and
Proteins Related to Mitochondrial Function Is
Altered in Late-Passage Mutant Corneal
Fibroblasts
To determine whether alterations occur in the mitochon-
drial protein content in the mutant corneal fibroblasts, the
al fibroblasts in passages 4 and 8. Expression of complexes I, II, and IV was
as that of complex III was increased in the late passage of wild-type. Levelst corne
ts, whereph indicates the relative ratio considering the expression level of wild-type
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of the respiratory chain were measured using Western
blot analysis. Statistically significant reductions in com-
plexes I, II, and IV were observed in late-passage mutant
corneal fibroblasts; whereas the level of complex III was
increased in late-passage wild-type corneal fibroblasts,
and the levels of complexes I, II, IV, and V were un-
changed (Figure 6).
Expression of ANT-1 demonstrated a statistically
significant decrease in late-passages mutant cells,
and PGC-1, p-Akt (Ser 473), p-Akt (Thr 308), and
p-mTOR (Ser 2481) exhibited a statistically significant
decrease in late passages of both wild-type and mu-
tant cells (Figure 7A). To test the effect of PGC-1
expression on NF-B in nulcei, the expression of both
was analyzed using Western blot analysis in nuclear
extract. The expression pattern of PGC-1 in cellular
extract did not demonstrate the direct correlation with
NF-B expression in nuclei; however, expression pat-
terns of PGC-1 and NF-B in nuclear extract were
similar (Figure 7B).
Figure 7. Western blot analysis of proteins involved in mitochondrial functi
ANT-1 demonstrates a statistically significant decrease in late passages of m
demonstrated a statistically significant decrease in late passages of both w
increased in late-passage or mutant fibroblasts in similar pattern. The y axis of each g
fibroblasts in passage 4 as 1.0.Change in Intracellular ROS and Proliferation
before and after Application of BHA
The intracellular ROS level increased in late- passage
wild-type cells and decreased in late-passage mutant
cells. However, after treatment with 100 mol/L BHA, the
intracellular ROS level showed similar levels in all types of
cells (Figure 8A). In addition, at 24 hours after application
of 10 or 100 mol/L BHA, cellular proliferation of passage
8 mutant cells measured with MTS increased significantly
(Figure 8B).
Discussion
GCD2 is an abnormal condition of granular and lattice-
type corneal deposits that interfere with vision. The dis-
ease can be diagnosed at the molecular level by the
presence of specific mutations.13–15 Patients heterozy-
gous for GCD2 mutations exhibit generally mild corneal
opacities that slowly progress until they are in their thir-
ties, and initial clinical impairment in these patients usu-
ld-type and mutant corneal fibroblasts in passages 4 and 8. A: Expression of
lls, and PGC-1, p-Akt (Ser 473), p-Akt (Thr 308), and p-mTOR (Ser 2481)
and mutant cells. B: Expression of PGC-1 and NF-B in nuclear extracton in wi
utant ce
ild-typeraph indicates the relative ratio considering the expression level of wild-type
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severity of the corneal deposits increases with age. Re-
cently, a refractive procedure that induces rapidly pro-
gressive severe corneal opacities that cannot be con-
trolled without amputation of the flap or graft replacement
has been reported for treatment of GCD2.16,17 Because
of the unexpected progression of corneal opacity and the
relatively high incidence in Asian countries,18 where a
large number of refractive procedures are performed,
GCD2 is gaining attention in ophthalmology. Clinicians
now attempt to prevent serious deterioration by using
meticulous preoperative corneal evaluation for diagnosis
of GCD2 and are making an effort to understand the
major factors that exacerbate the natural course of cor-
neal dystrophy.19
Whereas heterozygous cornea demonstrate a naturally
slow progression of abnormalities, homozygous cornea
are characterized by significant visual impairment
caused by white dense deposits from early child-
hood.20,21 Thus, the homozygous R124H point mutation
of the gene encoding the TGFBI protein may increase
formation of deposits or have higher toxicity than does
the heterozygous mutation of the inducing protein.
Previously, the pathogenesis of GCD2 was thought to
be caused by numerous electron-dense fusiform depos-
its identified as hyaline or amyloid at histochemistry and
electron microscopy.22 However, after refractive proce-
dures, even the mutated state did not change the com-
Figure 8. Intracellular ROS staining and MTS assay after application of BHA.
Intensity of intracellular ROS staining increased in late passage of wild-type
cells, and decreased in late passage of mutant cells. A: After treatment with
100 mol/L BHA, the intensity of intracellular ROS decreased in all types of
cells. B: At 24 hours after application of 10 or 100 mol/L BHA, cellular
proliferation of passage 8 mutant cells increased statistically significantly in
MTS assay.ponent of the mutant protein, and other factors such assurgical trauma or cutting the edge of the collagen struc-
ture abruptly resulted in deteriorated corneal deposits.
Our group recently reported that increased intracellular
ROS and oxidative damage induced by decreased cat-
alase is involved in GCD2 pathogenesis.23 In addition,
increased oxidative stress led to a more sensitive re-
sponse in homozygous corneal fibroblasts. In the present
study, keratocytes located near the stromal deposit dem-
onstrated degenerative change and damaged intracellu-
lar structure on electron microscopic images. In seems
that in addition to the deposits themselves, the increased
cellular stress caused by mutated protein production,
secretion, and absorption and the altered metabolism
induced by increased oxidative stress may be involved in
progression of the disease.
In the present study, we focused on and evaluated the
state of mitochondria in GCD2 mutant corneal fibroblasts,
in tissue, and under cultured conditions. The keratocytes
surrounding the corneal deposits of GCD2 heterozygous
cornea demonstrated degenerative changes including
swollen and damaged mitochondria. To simulate the ag-
ing condition in our in vitro culture system, we compared
corneal fibroblasts from an early passage4 and a late
passage.8 To avert the age-related changes in mitochon-
drial function in the primary culture cells, we used healthy
corneas from 20-year-old individuals and mutant cells
from 8-year-old patients. Passage 8 was selected as a
late passage because apparent retardation of cellular
growth was observed in this passage in several prelimi-
nary trials (data not shown), and the halfway point (pas-
sage 4) was chosen as the early passage. In contrast to
the small round mitochondria in wild-type cells in the
early and late passages, a large number of elongated
mitochondria were observed in early-passage mutant
cells, whereas in late-passage mutant cells, the number
of mitochondria was decreased.
In experiments performed to observe mitochondrial
activity using MitoTraker and cytochrome c staining, mu-
tant cells demonstrated increased detection of both
markers of mitochondrial function, specifically in the early
passage. However, the signal was abruptly decreased in
the late passage, whereas wild-type cells maintained the
same staining intensity.
The loss of mitochondrial membrane potential is a hall-
mark of apoptosis. It is an early event that precedes
phosphatidylserine externalization and coincides with
caspase activation.24,25 In nonapoptotic cells, JC-1 ex-
ists as a monomer in the cytosol (green) and accumu-
lates as aggregates in the mitochondria, which stain red.
In apoptotic and necrotic cells, JC-1 exists in monomeric
form and stains the cytosol green. Compared with other
cells, late-passage mutant cells demonstrated a statisti-
cally significant reduction in the percentage of red fluo-
rescence. Delayed proliferation and cellular viability was
observed in mutant cells in MTS and CCK-8 assays. Cell
viability was maintained for 6 hours under culture condi-
tions, but from 24 hours significantly decreased levels of
each marker were observed. Annexin V stain demon-
strated typical apoptotic feature in mutant cells, in par-
ticular in the late passage. All of these findings suggest
that the mitochondria of corneal fibroblasts may be im-
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passages.
The membrane-bound mitochondrial complexes I to V
pathway establishes a proton gradient across the mito-
chondrial membrane, producing a thermodynamic state
with potential to do work. A small percentage of electrons
prematurely leak oxygen, resulting in formation of the
toxic free-radical superoxide, a molecule thought to con-
tribute to a number of diseases and aging.26,27 Wild-type
corneal fibroblasts demonstrated unchanged or in-
creased activity of complexes I to V. In contrast, mutant
cells exhibited decreased expression of complexes I to V
in the late passages. This indicates that mutant cells lose
their mitochondrial function to generate energy and redox
reactions in later passages.
Mammalian target of rapamycin (mTOR) is a large
serine/threonine protein kinase of approximately 280 kDa
that forms multiple subunit complexes with numerous
protein partners. In mammalian cells, two distinct com-
plexes have been identified: mTORC1, in which mTOR is
bound to the protein partner raptor, and mTORC2, in
which mTOR is bound to another protein partner, rec-
tor.28,29 These protein complexes have distinct biological
functions such as a role in metabolism during aging and
a role in the Akt/mTOR pathway during the life span,
determined by regulating mitochondrial oxygen con-
sumption and oxidative capacity.30 Transcriptional com-
plexes that contain PGC1 control mitochondrial oxida-
tive function to maintain energy homeostasis in response
to nutrient and hormone signals. Expression of PGC-1
relates to the NF-B pathway.31 To evaluate the correlation
of each factor, expression of NF-B and PGC-1 in nuclei
was analyzed. Expression of PGC-1 in the cellular com-
ponent decreased in late passages of both cell types. How-
ever, in the nuclear extraction component, expression of
NF-B and PGC-1 increased in mutant cells. Therefore,
the correlation betweenNF-B and PGC-1 expression was
observed in the nuclear component.
In a previous study, mTOR regulated mitochondrial
gene expression and oxygen consumption by controlling
the gene expression of the mitochondrial transcriptional
regulator PGC-1 and other nuclear respiratory factors.32
ANT was observed to be the only protein in the mitochon-
drial membrane that exhibits a detectable age-associ-
ated increase in carbonyls. The age-related increase in
molecular oxidative damage to mitochondrial membrane
proteins is primarily due to the severe loss of ANT activ-
ity.33 VDAC has a central role in mitochondria-mediated
apoptosis. Cytochrome c and other small molecules pass
through the mitochondrial permeability transition pore,
which comprises VDAC in the outer membrane, ANT in
the inner membrane, and several auxiliary proteins that
include the Bcl-2 family involved in apoptosis.34,35 With
the exception of VDAC, expression of these proteins
demonstrated a passage-dependent decrease in both
wild-type and mutant cells.
Intracellular ROS was measured directly using CM-
H2DCFDA by obtaining DCF fluorescence images. Intra-
cellular ROS increased in late passage of wild-type cells
and early passage of mutant cells. The different levels of
intracellular ROS were equalized by application of theknown antioxidant BHA. Not only the level of intracellular
ROS but cellular proliferation measured using MTS
changed significantly in late passage of mutant cells after
application of BHA. Thus, increased mitochondrial stress
and altered cellular viability of mutant cells were modu-
lated by application of the proper antioxidant.
Our results suggest that mutation of GCD2 may affect
mitochondrial activity via abnormal protein production or
increased oxidative stress23 rather than a direct change
in functional mitochondrial proteins. Thus, antioxidants
may be an applicable modulator for rescue of GCD2-
induced cellular toxicity. Any effort to reduce mitochon-
drial stress in the cornea, for example, averting mechan-
ical trauma or UV light, would be helpful.
In conclusion, the GCD2 mutation is associated with
altered mitochondrial structure and activity and delayed
cellular proliferation in aged cells. Though it cannot be
concluded that the mitochondrial changes are the cause
of the disease or a byproduct of the mutated GCD2
protein, it seems that the decreased mitochondrial activ-
ity is related more to the mutation than to aging. There-
fore, alteration of mitochondrial function is critical for un-
derstanding the pathogenesis and potential treatment of
GCD2.
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